During the past decade, Cardiology PC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiology PC" #1 collaborator was "Medtronic" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Cardiology PC" are "Coronary Artery Disease" (2 trials), "Myocardial Infarction" (2 trials), "Acute Coronary Syndrome" (1 trials), "Coronary Artery Disease (CAD)" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Cardiology PC" in a lesser frequency.

Most popular intervention types in "Cardiology PC" are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "A-002" (2 trials), "Ambrisentan" (1 trials), "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials), "Plavix (clopidogrel 75 mg) and aspirin" (1 trials) and "Protecta DR-ICD or CRT-D" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiology PC" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Cardiology PC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Cardiology PC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiology PC, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".